Header Logo

Connection

DAVID POPLACK to Central Nervous System Neoplasms

Back to Details
This is a "connection" page, showing publications DAVID POPLACK has written about Central Nervous System Neoplasms.
DAVID POPLACK
Connection Strength
0.057
Central Nervous System Neoplasms
  1. Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.